MedPath

LUMYKRAS 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

LUMYKRAS 240 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Commercialized
Register Number

1211603004

Prescription Type

Diagnóstico Hospitalario

Authorization Date

May 23, 2024

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1211603004
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

SOTORASIBActive
Quantity: 240 mg
Name: SOTORASIB

ATC CLASSIFICATION (3)

L01X
L01XX
L01XX73

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.